TAZLESTOBART
UNII 7QW97A6ZTH

Substance Identification & Data

This profile provides standardized clinical and technical data for Tazlestobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7QW97A6ZTH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2850355-80-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7QW97A6ZTH
CAS Registry Number
2850355-80-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TAZLESTOBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C207001
National Cancer Institute reference terminology for clinical and research data.
INN ID
12964
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tazlestobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV3-30*01 (94.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, G1V6 CH2 A85.4, A118, A119 (CH1 R120 (215) (119-216), HINGE 1-15 (217-231), CH2 S85.4>A (299), E118>A (334), K119>A (335), (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)), (221-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-215') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (97.9%) -IGKJ1*01 (100%), CDRI-MGT (7.3.9) (27'-33'.51'-53'.90'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154'), V101 (192') (109'-215')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (299-ALANINE,334-ALANINE,335-ALANINE), ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS MONOCLONAL IMM27M .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IMM27M .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC TLYMPHOCYTE ASSOCIATED PROTEIN 4, CTLA-4, CD152)), HUMANIZED MONOCLONAL ANTIBODY
TAZLESTOBART
TAZLESTOBART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus